Clinical Infectious Diseases · 2022 · 30 citations · 44 references
MedicineInfectious DiseasesMicrobiologyDiagnostic MicrobiologyMedical MicrobiologyVentilationPathogen DetectionPulmonary InfectionsRespiratory InfectionsRespiratory Tract InfectionsVolatile Organic CompoundsVolatile Substance AnalysisBreath Analysis MethodologyBreath Biomarker DetectionBronchoalveolar Lavage AnalysisEscherichia ColiExhaled Breath AssessmentMicrobial Volatile CompoundsMicrobial Volatile Organic CompoundsRespiratory Microbiology
BACKGROUND: Early and accurate recognition of respiratory pathogens is crucial to prevent increased risk of mortality in critically ill patients. Microbial-derived volatile organic compounds (mVOCs) in exhaled breath could be used as noninvasive biomarkers of infection to support clinical diagnosis. METHODS: In this study, we investigated the diagnostic potential of in vitro-confirmed mVOCs in the exhaled breath of patients under mechanical ventilation from the BreathDx study. Samples were analyzed by thermal desorption-gas chromatography-mass spectrometry. RESULTS: Pathogens from bronchoalveolar lavage (BAL) cultures were identified in 45 of 89 patients and Staphylococcus aureus was the most commonly identified pathogen (n = 15). Of 19 mVOCs detected in the in vitro culture headspace of 4 common respiratory pathogens (S. aureus, Pseudomonas aeruginosa, Klebsiella pneumoniae, and Escherichia coli), 14 were found in exhaled breath samples. Higher concentrations of 2 mVOCs were found in the exhaled breath of patients infected with S. aureus compared to those without (3-methylbutanal: P < .01, area under the receiver operating characteristic curve [AUROC] = 0.81-0.87; and 3-methylbutanoic acid: P = .01, AUROC = 0.79-0.80). In addition, bacteria identified from BAL cultures that are known to metabolize tryptophan (E. coli, Klebsiella oxytoca, and Haemophilus influenzae) were grouped and found to produce higher concentrations of indole compared to breath samples with culture-negative (P = .034) and other pathogen-positive (P = .049) samples. CONCLUSIONS: This study demonstrates the capability of using mVOCs to detect the presence of specific pathogen groups with potential to support clinical diagnosis. Although not all mVOCs were found in patient samples within this small pilot study, further targeted and qualitative investigation is warranted using multicenter clinical studies.
44
Proposed minimum reporting standards for chemical analysis
Lloyd W. Sumner, Alexander Amberg, Michael H. Beale et al. · Metabolomics · 2007 · 5K citations · Full text
Extensive impact of non-antibiotic drugs on human gut bacteria
Lisa Maier, Mihaela Pruteanu, Michael Kuhn et al. · Nature · 2018 · 1.9K citations · Full text
Antoní Torres, Michael S. Niederman, Jean Chastre et al. · European Respiratory Journal · 2017 · 1.4K citations · Full text
Association of Adverse Events With Antibiotic Use in Hospitalized Patients
Pranita D. Tamma, Edina Avdic, David X. Li et al. · JAMA Internal Medicine · 2017 · 778 citations · Full text